DOCSLIB.ORG

(ECT) for Depressive Illness, Schizophrenia, Catatonia and Mania

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
(ECT) for Depressive Illness, Schizophrenia, Catatonia and Mania Electroconvulsive therapy (ECT) for depressive illness, schizophrenia, catatonia and mania Report commissioned by: NHS R&D HTA Programme On behalf of: The National Institute for Clinical Excellence Produced by: The School of Health and Related Research (ScHARR), University of Sheffield Nuffield Institute for Health, University of Leeds Authors: Ms Joanne Greenhalgh, Research Officer, Nuffield Institute for Health Mr Chris Knight, Senior Operational Research Analyst, ScHARR Dr D Hind, Research Associate, ScHARR Ms C Beverley, Systematic Reviews Information Officer, ScHARR Mr. Stephen Walters, Medical Statistician, ScHARR Correspondence to: Ms Joanne Greenhalgh, Nuffield Institute for Health, University of Leeds, 71-75 Clarendon Road, Leeds, LS2 9PL Date completed: Expiry Date: Expiry date 1 PUBLICATION INFORMATION Referencing Information. ABOUT THE TRENT INSTITUTE Trent Institute for Health Services Research is a collaborative venture between the Universities of Leicester, Nottingham and Sheffield, with support from NHS Executive Trent. Members of staff in the Sheffield Unit, based in the School of Health and Related Research (ScHARR), have been engaged in reviewing the effectiveness and cost-effectiveness of health care interventions in support of the National Institute for Clinical Excellence. In order to share expertise on this work, we have set up a wider collaboration, InterTASC, with units in other regions. These are The Wessex Institute for Health Research and Development, Southampton University, The University of Birmingham Department of Public Health and Epidemiology, The Centre for Reviews and Dissemination, University of York. CONTRIBUTIONS OF AUTHORS Joanne Greenhalgh and Daniel Hind carried out the review of clinical effectiveness. Chris Knight carried out the review of cost effectiveness. Catherine Beverley carried out the electronic searches. Stephen Walters provided statistical advice. Joanne Greenhalgh is responsible for the report as lead author. CONFLICTS OF INTEREST Source of funding This report was commissioned by the NHS R&D HTA programme. Relationship of reviewer(s) with sponsor None of the authors has any financial interests in the companies producing or marketing ECT machines. ACKNOWLEDGEMENTS Paul Birkett, Clinical lecturer in Psychiatry, Charlie Brooker, Professor of Psychiatry, both in Sheffield and Simon Gilbody, Lecturer in Clinical Psychiatry and David Cottrell, Professor of child and adolescent psychiatry, provided clinical advice and guidance. Clive Adams gave clinical and methodological guidance and provided the group with the raw data from the recently updated Cochrane Group Review of ECT in schizophrenia. The UK ECT group provided the group with a copy of their report prior to publication. Suzy Paisley provided guidance on literature searching, proof reading, and guidance in the production of the report. Suzy Paisley, Ron Akehurst and Jim Chillcott (ScHARR), Dr. Niall Moore, Consultant Psychiatrist, Bristol, Dr. Douglas Gee, Consultant Psychiatrist, Humberside, Sarah Garner and Tina Eberstein (NICE) provided comments on the initial draft of the report. All responsibility for the contents of the report remains with the authors. 2 CONTENTS List of Abbreviations 6 Summary 8 1 Aim of the Review 11 2 Background 12 2.1 Description of the underlying health problem 12 2.1.1 Schizophrenia 12 2.1.2 Depression 12 2.1.3 Mania 13 2.1.4 Catatonia 13 2.1.5 Epidemiology 13 2.2 Current service provision 14 2.2.1 Description of intervention 14 2.2.2 Patient populations 14 2.2.3 Stimulus parameters and administration of ECT 16 2.2.4 Information and consent 17 2.2.5 Current service provision in England and Wales 18 2.2.6 Training and the quality of ECT services 19 2.2.7 Current mental health policy in England and Wales 20 3 Effectiveness 20 3.1 Methods for reviewing effectiveness 20 3.1.1 Search strategy: clinical effectiveness 20 3.1.2 Search strategy: cost effectiveness 21 3.1.3 Inclusion and exclusion criteria 21 3.1.4 Quality assessment and data extraction strategy 22 3.2 Results 24 3.2.1 Quantity of research available 24 3.2.2 Quality of studies identified 30 3.2.3 Depression 36 3.2.4 Mania 46 3.2.5 Schizophrenia 46 3.2.6 Specific outcomes not covered by the randomised evidence 51 3.2.7 The efficacy of ECT in specific subgroups 53 3.2.8 Conclusions and discussion 59 4 Economic Analysis 60 4.1 Introduction 60 4.1.1 Search Strategy 60 4.1.2 Overview of Economic Literature Review and Economic 60 Evidence 4.2 Economic Modelling of ECT for depressive illness, 60 schizophrenia, catatonia and mania 4.2.1 Modelling Depressive Illness 60 4.2.2 Introduction 60 4.2.3 Methodology 61 4.2.4 Assumptions and Probabilities 63 4.2.5 Results 73 4.2.6 Sensitivity Analysis 78 4.2.7 Conclusions 81 4.2.8 Further Areas of Research 81 4.3 Modelling Schizophrenia 81 4.3.1 Introduction 81 3 4.3.2 Methodology 82 4.3.3 Results 86 4.3.4 Sensitivity Analysis 86 4.3.5 Conclusions and Recommendations 87 5 Implications for OTHER Parties 88 6 Factors Relevant to the NHS 88 7 Discussion 89 7.1 Summary of Main results and discussion 89 7.1.1 Depressive illness 89 7.1.2 Schizophrenia 92 7.1.3 Mania 94 7.1.4 Catatonia 94 7.1.5 Children and adolescents 94 7.1.6 Older people 95 7.1.7 Pregnancy 95 7.1.8 Long term efficacy of ECT 95 7.1.9 Adverse events: mortality 95 7.1.10 Adverse events: cognitive functioning 95 7.1.11 Adverse effects: brain damage 95 7.1.12 Patient acceptability in choice 95 7.1.13 Patient information and consent 95 7.2 Assumptions, limitations and uncertainties 96 7.2.1 Comprehensiveness of the review 96 7.3 Need for further research 96 8 Conclusions 98 8.1 Clinical effectivess 98 8.2 Cost effectiveness 98 APPENDICES Appendix 1 Electronic Bibliographic Databases Searched 100 Appendix 2 Other Sources Consulted 101 Appendix 3 Search Strategies Used in the Major Electronic Bibliographic 102 Databases Appendix 4 Methodological Search Filters Used in Ovid Medline 112 Appendix 5: Descriptions of included studies 112 Appendix 6 TABLES Table 1: Overlap between NICE scope and the 6 systematic review 26 identified Table 2: NICE scope and sources of evidence used 27 Table 3: Summary of efficacy of ECT in children and adolescents from 55 Rey and Walters(1) Table 4: Clinical Success for Pharmacological and ECT Interventions in 66 Major Depression Table 5: Failure to complete Treatment Rates 66 Table 6: Maintenance Therapy Relapse Assumptions 67 Table 7: Cost of Acute Treatment for Major Depression 68 4 Table 8: Cost of Continuation/Maintenance Therapy for Major 69 Depression Table 9: QoL Utility assumptions 71 Table 10: Summary of Model Scenarios 72 Table 11: Treatment Scenario Results 73 Table 12: Analysis of the Incremental Net Benefit 75 Table 13: Scenario Results based on Revicki QALYs 79 Table 14: ICER Analysis using scenarios based on Revicki QALYs 79 Table 15: Scenario Results based on reduction of 25% in ECT Cost 80 Table 16: ICER Analysis using scenarios based on a 25% reduction in 80 ECT Cost Table 17: Event Probabilities 84 Table 18: Quality of Life Utility Estimates 85 Table 19: Dosage and Cost Estimates 85 Table 20: Cost-Effectiveness Results 86 Table 21: Threshold Analysis for Treatment-Resistant Schizophrenia 86 Table A 5.1 Systematic reviews of the clinical effectiveness and safety of 115 ECT in depression, schizophrenia and mania Table A5.2 Systematic reviews of non randomised evidence: patient 117 acceptability and choice Table A5.3 Systematic reviews of non-randomised evidence: children and 118 adolescents Table A5.4 Systematic reviews of non-randomised evidence: Catatonia 119 Table A5.5 Systematic review of non randomised evidence: Use of ECT in 120 pregnancy Table A5.6 Randomised controlled trials comparing real vs sham ECT: 121 depression Table A5.7 Randomised controlled trials comparing ECT with 128 phamacotherapy: depression Table A5.8 Randomised controlled trials of ECT compared with rTMS in 142 depression Table A5.9 Randomised controlled trials of ECT plus pharmacotherapy vs 143 ECT plus placebo/pharmacotherapy only 2: Depression Table A5.10 Randomised controlled trials comparing ECT+ 148 pharmacotherapy/placebo + continuation pharmacotherapy: Depression Table A5.11 Randomised controlled trials comparing continuation 152 pharmacotherapy only Table A5.12 RCTS of patient information videos 158 Table A5.13 Non randomised evidence of efficacy of ECT in older people 156 with depression Table A5.14 Non randomised evidence: Children and adolescents 156 Table A5.15 Non randomised evidence: Catatonia 158 Table A5.16 Non randomised evidence: pregnancy 159 160 FIGURES Figure 1 Decision model - depressive illness 62 Figure 2 Treatment success rate 65 Figure 3 Cost-effective acceptability curves 77 5 Figure 4 Cost-effective acceptability curves 78 Figure 5 One-year Treatment Resistant Schizophrenic Treatment Model 83 6 LIST OF ABREVIATIONS APA American Psychiatric Association BBB Blood Brain Barrier BDI Beck Depression Inventory BGT Bender Gestalt Test BPRS Brief Psychiatric Rating Scale C. TCA Continuation Therapy with TCAs C.ATP Continuation Therapy with antipsychotic drugs C.MAOI Continuation Therapy with MAOIs C.placebo Continuation therapy with placebo C.SSRI Continuation Therapy with SSRIS CASP CEAC Cost Efectiveness Acceptabilty Curve CECT Continuation ECT CGI Clinical Global Inpression CIRS Cumulative Illness Rating Scale CODS Cronholme and Ottoson Rating Scale CONSORT recommendations CT Computerised tomography CTCA+LI Continuation therapy with Lithium and TCAs DSM Diagnostic and Statistical Manual EEG GAF Global
Load more

Recommended publications
  • Psychosis, Catatonia and Post-Psychosis PTSD
    British Journal of Medicine & Medical Research 15(8): 1-5, 2016, Article no.BJMMR.26114 ISSN: 2231-0614, NLM ID: 101570965 SCIENCEDOMAIN international www.sciencedomain.org Psychosis, Catatonia and Post-psychosis PTSD Evita Rocha 1, Andrei Novac 2, Daniel Kirsten 1, Jiwon Shin 3, Diana Totoiu 4 and Robert G. Bota 3* 1Resident Psychiatry, UC, Irvine, USA. 2Department of Psychiatry, UC, Irvine, USA. 3UC Irvine, USA. 4Department of Psychology, Cal State Fullerton, USA. Authors’ contributions This work was carried out in collaboration between all authors. Author ER wrote the first draft of the case reports and helped with literature search and part of introduction. Author AN contributed the writing of the manuscript and formulated the theoretical frame of the psychopathology. Authors DK, JS, DT managed the literature searches, contributed to writing of the manuscript and edited the final versions. Author RGB designed the study, supervised the process and wrote parts of the manuscript. All authors read and approved the final manuscript. Article Information DOI: 10.9734/BJMMR/2016/26114 Editor(s): (1) Domenico De Berardis, Department of Mental Health, National Health Service, Psychiatric Service of Diagnosis and Treatment, “G. Mazzini” Hospital, Italy. Reviewers: (1) Sara Marelli, Vita-Salute San Raffaele University, Milan, Italy. (2) Takashi Ikeno, National Center of Neurology and Psychiatry, Japan. Complete Peer review History: http://sciencedomain.org/review-history/14521 Received 1st April 2016 nd Case Study Accepted 2 May 2016 Published 9th May 2016 ABSTRACT We are describing the case of a 27-year-old female with no previous psychiatric history who developed post-psychotic PTSD after presenting with first episode catatonia and psychosis.
    [Show full text]
  • Cannabis-Induced Catatonia: a Case Series
    Open Access Case Report DOI: 10.7759/cureus.8603 Cannabis-Induced Catatonia: A Case Series Hema Mekala 1 , Zamaar Malik 2 , Judith Lone 2 , Kaushal Shah 1 , Muhammad Ishaq 1 1. Psychiatry, Griffin Memorial Hospital, Norman, USA 2. Psychiatry, Medical University of the Americas, Camps, KNA Corresponding author: Kaushal Shah, [email protected] Abstract Catatonia is a psychomotor condition characterized by physical presentations ranging from severe immobility to excessive psychomotor agitation with an array of accompanying emotional aspects. Though initially thought to be a subform of schizophrenia, it is now recognized to be associated with many different psychiatric, neurological, and medical diagnoses. The emergence of catatonia is becoming more prevalent with its changing pattern and extensive use of recreational and illegal drugs. With the legalization of marijuana, its use is on the rise leading to several mental health conditions, including catatonia. If left untreated, catatonia has a significant morbidity and mortality rate; hence, prompt evaluation and diagnosis are critical for the prevention of adverse events. Benzodiazepines (BZDs) and electroconvulsive therapy (ECT) have been found to be most effective and remained as the preferred treatment options. In this paper, we present the case of two patients who presented with catatonia after cannabis consumption and discuss their treatment course and management. Categories: Emergency Medicine, Neurology, Psychiatry Keywords: synthetic cannabis, k2, cannabis, catatonia, addiction, thc, schizophrenia, benzodiazepine, ect, psychiatry Introduction Catatonia is a common condition observed in acutely ill patients with mental health conditions. In the United States, approximately 90,000 people tend to suffer from catatonia each year, with a prevalence ranging between 7.6% to 38% [1].
    [Show full text]
  • Movement Disorders in Catatonia Subhashie Wijemanne, Joseph Jankovic
    Movement disorders J Neurol Neurosurg Psychiatry: first published as 10.1136/jnnp-2014-309098 on 19 November 2014. Downloaded from REVIEW Movement disorders in catatonia Subhashie Wijemanne, Joseph Jankovic ▸ Additional material, ABSTRACT between 7.6% and 38% among all psychiatric including videos, is published Catatonia is a complex neuropsychiatric syndrome patients.10 The percentage of catatonia due to a online only. To view please characterised by a broad range of motor, speech and general medical condition is reported to range visit the journal online (http:// 11 dx.doi.org/10.1136/jnnp-2014- behavioural abnormalities. ‘Waxy flexibility’, ‘posturing’ from 20% to 39%. Catatonia may be subtle and 309098). and ‘catalepsy’ are among the well-recognised motor overlooked, which may account for reports suggest- Department of Neurology, abnormalities seen in catatonia. However, there are ing a declining incidence. People with bipolar disor- Parkinson’s Disease Center and many other motor abnormalities associated with ders probably constitute the largest subgroup of Movement Disorders Clinic, catatonia. Recognition of the full spectrum of the catatonic patients.51012In a minority of cases, no Baylor College of Medicine, phenomenology is critical for an accurate diagnosis. cause is found and the current prevalence of idio- Houston, Texas, USA Although controlled trials are lacking benzodiazepines pathic catatonia is unknown. Correspondence to are considered first-line therapy and N-Methyl-D- Owing to the wide range of underlying diagnoses, Dr Joseph Jankovic, aspartate receptor antagonists also appears to be patients with catatonia may present as a medical or Department of Neurology, effective. Electroconvulsive therapy is used in those psychiatric emergency13 or develop symptoms ’ Parkinson s Disease Center and patients who are resistant to medical therapy.
    [Show full text]
  • Presence of Isolated Catatonic Signs in Chronic Psychosis
    JOURNAL OF PSYCHOPATHOLOGY Case report 2018;24:237-238 K. Navin, G. Sathyanarayanan, Presence of isolated catatonic signs B. Bharadwaj in chronic psychosis: Department of Psychiatry, Jawaharlal Institute of Postgraduate Medical Education & is chronic catatonia under-recognised? Research, Puducherry, India A case series Introduction Catatonia is a complex syndrome of specific motor abnormalities associ- ated with various psychiatric disorders. Historically, more than 50 clinical signs have been described in catatonia, however, it is now confined to the 23 signs mentioned in the Bush-Francis Catatonia Rating Scale 1. In clinical practice we are apt to recognise catatonia in its stuporous form presenting in emergency with risks due to compromised food and water intake and immobility. Excited catatonia is often missed or diagnosed in hindsight when it presents with manic excitement 2. In this case series we want to highlight that the presence of a few catatonic signs may often be missed as has been pointed out earlier 3. This under-recognition may account for the discrepancy between findings in literature 4. In the Inter- national Pilot Study of Schizophrenia (IPSS) though catatonic signs were noted in 96 patients only a few among them were diagnosed as catatonic schizophrenia. Conversely, most of the 55 patients diagnosed as having catatonic schizophrenia did not have catatonic symptoms 5. In this case series, we would like to present three patients with persistent catatonic symptoms occurring during their psychotic illnesses. The cata- tonic signs were recognized on clinical evaluation. The signs specifically re- sponded to treatment with lorazepam and in two of the cases, drug default or attempts to taper the dose; led to resurgence of catatonic symptoms.
    [Show full text]
  • Catatonia: an Under-Recognised, Acutely Treatable Condition in Young People with Intellectual Disability/ASD
    Catatonia: an under-recognised, acutely treatable condition in young people with intellectual disability/ASD. Associate Professor David Dossetor The Children’s Hospital at Westmead Area Director for Mental Health Child Psychiatrist with a Special interest in Intellectual Disability A case example inaudible words in the consultation and didn’t A 15-year-old girl with Down Syndrome was referred to respond to questions. She had waxy flexibility and neurology due to a neurocognitive decline over a two- mild increased muscle tone. She drew a few small month period. She had been socially active, happy, indistinct pictures and was eventually able to write cheeky, talkative and an enthusiastic school attender. her name. She appeared to respond to unseen She had acquired basic self-care and hygiene skills, stimuli. There was no access to her internal mental and achieved primary school educational skills. At a state but she did laugh to herself regularly, out of school swimming carnival, the girl was severely context. It was not possible to assess her cognitive sunburnt. That night she became a little delirious and skills. was uncharacteristically incontinent; this incontinence persisted. The next day she was found sitting in bed The girl was diagnosed with a psychotic disorder with with arms out stiff and staring blankly. A GP review catatonic features and started on olanzapine 2.5mg revealed nothing, with a normal urine screen. Over the three times daily (tds), adding 0.5mg lorazepam tds next month she became progressively quieter until she a week later which was increased to 1mg tds two became mute. She also became apathetic and lost weeks later.
    [Show full text]
  • Catatonia in Depression: Prevalence, Clinical J Neurol Neurosurg Psychiatry: First Published As 10.1136/Jnnp.60.3.326 on 1 March 1996
    32632ournal ofNeurology, Neurosurgery, and Psychiatry 1996;60:326-332 Catatonia in depression: prevalence, clinical J Neurol Neurosurg Psychiatry: first published as 10.1136/jnnp.60.3.326 on 1 March 1996. Downloaded from correlates, and validation of a scale Sergio E Starkstein, Gustavo Petracca, Alejandra Teson, Eran Chemerinski, Marcelo Merello, Ricardo Migliorelli, Ramon Leiguarda Abstract mute and immobile, with staring expression, Objectives-To examine the clinical cor- gaze fixed into space, with an apparent com- relates of catatonia in depression, to vali- plete loss of will, no reaction to sensory stim- date a scale for catatonia, and to assess uli, sometimes with the symptom of waxy the validity of the DSM-IV criteria of the flexibility completely developed, as in catatonic features specifier for mood dis- catalepsy, sometimes of a mild degree, but orders. clearly recognisable," and labelled this state Methods-A series of 79 consecutive "vesania katatonica".2 Stressing that catatonia patients with depression and 41 patients was not related to "affective" melancholy with Parkinson's disease without depres- sensu strictu, Wernicke suggested the term sion were examined using the modified "motilitatpsychose", and suggested that this Rogers scale (MRS), the unified disorder may be the result of dysfunction of a Parkinson's disease rating scale "psychomotor path", producing either akine- (UPDRS), and the structured clinical sis, parakinesis, or hyperkinesis.3 Whereas interview for DSM-III-R (SCID). Kahlbaum and Wernicke placed catatonia Results-Sixteen of the 79 depressed within the range of the affective disorders, patients (20%) had catatonia. Depressed Kraepelin4 considered catatonia as a type of patients with catatonia had significantly schizophrenia, and this disorder aroused little higher scores on the MRS than non-cata- interest until recently.
    [Show full text]
  • Catatonia Associated with Late-Life Psychosis Successfully Treated With
    Sugawara et al. Ann Gen Psychiatry (2021) 20:14 https://doi.org/10.1186/s12991-021-00336-4 Annals of General Psychiatry CASE REPORT Open Access Catatonia associated with late-life psychosis successfully treated with lithium: a case report Hiroko Sugawara1,2*, Junpei Takamatsu3, Mamoru Hashimoto2 and Manabu Ikeda2 Abstract Background: Catatonia is a psychomotor syndrome that presents various symptoms ranging from stupor to agita- tion, with prominent disturbances of volition. Its pathogenesis is poorly understood. Benzodiazepines and electrocon- vulsive therapy (ECT) are safe and efective standard treatments for catatonia; however, alternative treatment strate- gies have not been established in cases where these treatments are either inefective or unavailable. Here, we report a case of catatonia associated with late-life psychosis, which was successfully treated with lithium. Case presentation: A 66-year-old single man with hearing impairment developed hallucination and delusions and presented with catatonic stupor after a fall. He initially responded to benzodiazepine therapy; however, his psychotic symptoms became clinically evident and benzodiazepine provided limited efcacy. Blonanserin was inefective, and ECT was unavailable. His catatonic and psychotic symptoms were fnally relieved by lithium monotherapy. Conclusions: Catatonic symptoms are common in patients with mood disorders, suggesting that lithium may be efective in these cases. Moreover, lithium may be efective for both catatonic and psychotic symptoms, as it nor- malizes imbalances of excitatory and inhibitory systems in the brain, which underlies major psychosis. Cumulative evidence from further cases is needed to validate our fndings. Keywords: Catatonia, Late-life psychosis, Lithium, Benzodiazepine, Psychotic symptoms Background schizophrenia (10–15%) [5]. A prospective cohort study Catatonia is a psychomotor syndrome that presents vari- has also reported the incidence of catatonia to be only ous symptoms ranging from stupor to agitation, with 7.6% in patients with schizophrenia [6].
    [Show full text]
  • Catatonia and Psychosis Related to Epilepsy: a Case Report Laiana Quagliato 1, Roberto Piedade 1, Cristina Santana 2, Elie Cheniaux 1
    Case Reports Catatonia and Psychosis Related to Epilepsy: A Case Report Laiana Quagliato 1, Roberto Piedade 1, Cristina Santana 2, Elie Cheniaux 1 Abstract Although a variety of metabolic, toxic, psychiatric, and neurologic conditions can produce catatonic syndromes, it is less widely recognized that this state may be caused by epilepsy. We present the case of a woman with catatonic behavior, which she could not recall. She also exhibited olfactory, auditory and visual hallucinations. An EEG demonstrated dif- fuse abnormal electrical activity, mainly on left temporal and frontal areas. Treatment with anticonvulsant drugs yielded excellent response. Key Words: Temporal Lobe Epilepsy, Catatonic Syndrome, Epileptic Psychosis Introduction To illustrate the importance of diagnosing catatonic syn- Catatonia is a syndrome characterized by motor dysreg- dromes properly, we report the case of a patient with cata- ulation and speech disorders (1). A variety of conditions can tonic behavior, auditory, visual and olfactory hallucinations produce catatonic states. Although the association between associated to epilepsy. epilepsy and catatonia has been pointed out in a few review articles (2, 3), little recognition and research have been de- Case Study voted to the association. In every case of catatonic syndrome, Mrs. F’s symptoms were first noticed by her husband a process of clarification of the etiological diagnosis must be when she was 49-years old. He reported that sometimes the performed systematically. patient would suddenly stop talking, turn her head and neck Epilepsy and psychosis coexist more frequently than a little to the right, stare motionless and not interact with chance would predict. Typically, psychotic symptoms closely anyone.
    [Show full text]
  • Catatonia in DSM-5
    Schizophrenia Research 150 (2013) 26–30 Contents lists available at ScienceDirect Schizophrenia Research journal homepage: www.elsevier.com/locate/schres Review Catatonia in DSM-5 Rajiv Tandon a,⁎, Stephan Heckers b, Juan Bustillo c, Deanna M. Barch d,e, Wolfgang Gaebel f, Raquel E. Gur g,h, Dolores Malaspina i,j, Michael J. Owen k, Susan Schultz l, Ming Tsuang m,n,o, Jim van Os p,q, William Carpenter r,s a Department of Psychiatry, University of Florida Medical School, Gainesville, FL, USA b Department of Psychiatry, Vanderbilt University, Nashville, TN, USA c Department of Psychiatry, University of New Mexico, Albuquerque, NM, USA d Department of Psychology, Washington University, St. Louis, MO, USA e Department of Psychiatry and Radiology, Washington University, St. Louis, MO, USA f Department of Psychiatry, Duesseldorf, Germany g Department of Psychiatry, Perlman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA h Department of Neurology and Radiology, Perlman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA i Department of Psychiatry, New York University, New York, NY, USA j Creedmoor Psychiatric Center, New York State Office of Mental Health, USA k MRC Centre for Neuropsychiatric Genetics and Genomics and Neuroscience and Mental Health Research Institute, Cardiff University, Cardiff, Wales, United Kingdom l Department of Psychiatry, University of Iowa School of Medicine, Iowa City, IA, USA m Center for Behavioral Genomics, Department of Psychiatry and Institute of Genomic Medicine, University
    [Show full text]
  • Catatonia, NMS, and Serotonin Syndrome
    Catatonia, NMS, and Serotonin Syndrome Christopher M. Celano, MD, FACLP Associate Director, Cardiac Psychiatry Research Program, Massachusetts General Hospital Assistant Professor of Psychiatry, Harvard Medical School October 22, 2020 www.mghcme.org Disclosure: Christopher Celano, MD Sunovion Company Pharmaceuticals Employment Management Independent Contractor Consulting Speaking & Teaching I Board, Panel or Committee Membership D – Relationship is considered directly relevant to the presentation I – Relationship is NOT considered directly relevant to the presentation www.mghcme.org Catatonia: How common is it? • 7.8-9.0% prevalence rate – Highest rates in non-psychiatric (i.e., medical) settings and in patients undergoing ECT. • 1.6-5.5% of all patients seen on psychiatry consultation service – Prevalence higher for older patients • Up to 46% of cases may have etiology that is not primarily psychiatric Grover 2015, Carroll 1994, Jaimes-Albornoz 2013, Fricchione 2008 www.mghcme.org When are you called? • Staff reports the patient is “Playing POSSUM” • Perseveration (speech or behavior) • Oppositionality to all requests • Speech that trails off or is whispereD • Slowed response to questions or commands • Undernourished (reports of decreased PO intake) • Motionless but awake www.mghcme.org Diagnosing Catatonia: DSM-5 DSM-5 requires 3 or more of the following: • Catalepsy • Posturing • Waxy flexibility • Mannerisms • Stupor • Stereotypies • Agitation • Grimacing • Mutism • Echolalia • Negativism • Echopraxia American Psychiatric Association 2013 www.mghcme.org Bush-Francis Rating Scale • Excitement • VerBigeration • Immobility/stupor • Rigidity • ComBativeness • Negativism • Autonomic Abnormality • Waxy flexiBility • Impulsivity • Withdrawal • Mutism • Automatic OBedience • Staring • Mitgehen • Posturing/catalepsy • Gegenhalten • Grimacing • AmBitendency • Echopraxia/echolalia • Grasp Reflex • Stereotypy • Perseveration • Mannerisms Bush 1996 www.mghcme.org Challenges with Diagnosis • Clarifying specific symptoms can be difficult – Rigidity vs.
    [Show full text]
  • Why Do Neurologists Miss Catatonia in Neurology Emergency? a Case
    Clinical Neurology and Neurosurgery 184 (2019) 105375 Contents lists available at ScienceDirect Clinical Neurology and Neurosurgery journal homepage: www.elsevier.com/locate/clineuro Why do neurologists miss catatonia in neurology emergency? A case series T and brief literature review ⁎ Sucharita Ananda, Vimal Kumar Paliwala, , Laxmi S Singha, Ravi Uniyalb a Department of Neurology, SGPGIMS, Raebareli road, Lucknow, UP, India b Department of Neurology, King George Medical University, Lucknow, UP, India ARTICLE INFO ABSTRACT Keywords: Catatonia is a well-described clinical syndrome characterized by features that range from mutism, negativism Catatonia and stupor to agitation, mannerisms and stereotype. Causes of catatonia may range from organic brain disorders Extrapyramidal disorder to psychiatric conditions. Despite a characteristic syndrome, catatonia is grossly under diagnosed. The reason for Parkinsonism missed diagnosis of catatonia in neurology setting is not clear. Poor awareness is an unlikely cause because Major depression catatonia is taught among conditions with deregulated consciousness like vegetative state, locked-in state and Schizophrenia akinetic mutism. We determined the proportion of catatonia patients correctly identified by neurology residents in neurology emergency. We also looked at the alternate diagnosis they received to identify catatonia mimics. Twelve patients (age 22–55 years, 7 females) of catatonia were discharged from a single unit of neurology department from 2007 to 2017. In the emergency department,
    [Show full text]
  • Catatonia in a Patient with Bipolar Disorder Type I
    Published online: 2019-11-13 Letters to the Editor [1] fluid (CSF). The presence of a high CSF: Serum ratio Access this article online of specific IgG antibodies against measles supports the Quick Response Code: diagnosis. Histological findings in sterotactic biopsies or necropsy studies are characterized by a chronic Website: leptomeningeal, perivascular, and parenchymatous www.ruralneuropractice.com chronic inflammatory infiltrate, with neuronal degeneration, gliosis, demyelinization, and astrocyte proliferation. Crowdy type A inclusion bodies are intranuclear or intracytoplasmatic viral particles found both in the neurons and glial cells. Neurofibrillary tangles is another characteristic finding, particularly Catatonia in a patient when the disease has been present for some years.[2,6] with bipolar disorder In adult patients with SSPE, clinical manifestations may be atypical and heterogeneous, with absence of type I myoclonus or EEG periodic complexes, as we can observe in Mahendra et al’s [7] case report; for this reason, a high clinical suspicion index for the diagnosis is required, Sir, and an extensive differential diagnosis should be made Catatonic symptoms can be present in any severe phase to exclude metabolic, demyelinating, genetic, infectious, of bipolar disorder (BD), when the specifier “with and paraneoplastic diseases.[8] In some cases, brain catatonic features” is applied to describe the particular biopsy has been the only method to establish a definitive episode (DSM‑5).[1] There is a wide range of catatonic diagnosis of the disease.[2,6] symptoms; manifestations can vary from negativism, withdrawal, staring, immobility/stupor, mutism, Adrià Arboix posturing, grimacing, stereotypies, and mannerisms to non‑purposeful excitement, undirected combativeness, Department of Neurology, Cerebrovascular Division, unexplained impulsive behavior, echopraxia and Hospital Universitari del Sagrat Cor, Universitat de Barcelona, Catalonia, Spain echolalia.
    [Show full text]